NanoVibronix, Inc.
General ticker "NAOV" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.6M (TTM average)
NanoVibronix, Inc. does not follow the US Stock Market performance with the rate: -32.8%.
Estimated limits based on current volatility of 4.9%: low 3.84$, high 4.23$
Factors to consider:
- Total employees count: 14 as of 2022
- US accounted for 94.4% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Pandemic risks, FDA approval delays, Regulatory and compliance, Market competition, Product liability
- Current price 84.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [25.54$, 86.28$]
- 2025-12-31 to 2026-12-31 estimated range: [14.69$, 52.41$]
Financial Metrics affecting the NAOV estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.57 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 17.28 <= 18.93
- Negative: 0.01 < Interest expense per share per price, % of 0.78
Short-term NAOV quotes
Long-term NAOV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.75MM | $2.28MM | $2.56MM |
| Operating Expenses | $5.76MM | $5.72MM | $6.14MM |
| Operating Income | $-5.01MM | $-3.44MM | $-3.58MM |
| Non-Operating Income | $-0.40MM | $-0.25MM | $-0.10MM |
| Interest Expense | $0.35MM | $0.25MM | $0.14MM |
| R&D Expense | $0.28MM | $0.18MM | $0.91MM |
| Income(Loss) | $-5.41MM | $-3.68MM | $-3.69MM |
| Taxes | $0.04MM | $0.03MM | $0.02MM |
| Profit(Loss)* | $-5.45MM | $-3.71MM | $-3.71MM |
| Stockholders Equity | $3.23MM | $3.99MM | $0.63MM |
| Inventory | $2.17MM | $2.73MM | $2.19MM |
| Assets | $5.88MM | $6.67MM | $3.63MM |
| Operating Cash Flow | $-7.04MM | $-3.60MM | $-2.52MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $-0.00MM | $-0.00MM |
| Financing Cash Flow | $2.09MM | $4.22MM | $0.00MM |
| Earnings Per Share** | $-38.38 | $-21.20 | $-13.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.